Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback